The study investigates the effects of psoralen (PSO) combined with ultraviolet A (UVA) on the apoptosis of human leukemia NB4 cells and the associated signaling pathways.
The research involved treating NB4 cells with varying concentrations of PSO and UVA exposure times, with apoptosis rates measured using flow cytometry and cell structure analyzed via electron microscopy.
Results indicate that the combination of PSO and UVA increases apoptosis in a dose- and time-dependent manner, particularly with 40 μg/mL PSO and 5 minutes of UVA, and enhances the expression of Caspase-3 and Caspase-8 proteins involved in the apoptosis process.